London, UK
,
December 21, 2020
Accelex, a data acquisition, analytics and reporting solution for private markets investors and asset servicers, is pleased to announce they have reached an agreement with a leading life sciences investor. Accelex will help this major European client automate the data extraction from hundreds of investment documents, including fund performance reports, capital account statements, capital call and distribution notices.
“With the growth of our private investments business, bringing automation to inefficient manual processes is paramount”, remarked the company’s director of portfolio valuations and performance. “We are excited by the data management opportunities Accelex brings to our firm. The solution enables us to deliver better performance reporting and analytics along with improved workflows for our cashflow events”.
“Our latest client is an internationally recognized investor in the field of life sciences. We are excited to deliver our solution as an integral part of their digital transformation” said Michael Aldridge, President at Accelex. “With the firm joining our growing community of major private markets investors, we are thrilled to partner with this outstanding organization in the provision of our market leading technology”.
Accelex, a data acquisition, analytics and reporting solution for private markets investors and asset servicers, is pleased to announce they have reached an agreement with a leading life sciences investor. Accelex will help this major European client automate the data extraction from hundreds of investment documents, including fund performance reports, capital account statements, capital call and distribution notices.
“With the growth of our private investments business, bringing automation to inefficient manual processes is paramount”, remarked the company’s director of portfolio valuations and performance. “We are excited by the data management opportunities Accelex brings to our firm. The solution enables us to deliver better performance reporting and analytics along with improved workflows for our cashflow events”.
“Our latest client is an internationally recognized investor in the field of life sciences. We are excited to deliver our solution as an integral part of their digital transformation” said Michael Aldridge, President at Accelex. “With the firm joining our growing community of major private markets investors, we are thrilled to partner with this outstanding organization in the provision of our market leading technology”.
Oops! Something went wrong while submitting the form.
About Accelex
Accelex provides data acquisition, analytics and reporting solutions for investors and asset servicers enabling firms to access the full potential of their investment performance and transaction data. Powered by proprietary artificial intelligence and machine learning techniques, Accelex automates processes for the extraction, analysis and sharing of difficult-to-access unstructured data. Founded by senior alternative investment executives, former BCG partners and successful fintech entrepreneurs, Accelex is headquartered in London with offices in Paris, Luxembourg, New York and Toronto. For more information, please visit accelextech.com
.svg)
